Instrumento Inactivo

Acciones Genzyme Corporation

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	28/06/11
Genzyme : succès de l'OPE de Sanofi-aventis.	04/04/11
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	07/03/11
Genzyme : Sanofi-aventis modifie son offre.	07/03/11
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	01/03/11

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31 %	103 mil M
REGENERON PHARMACEUTICALS, INC.	+0,56 %	95,28 mil M
ARGENX SE	+1,69 %	22,15 mil M
BIONTECH SE	-17,37 %	21,02 mil M
GENMAB A/S	-9,30 %	18,15 mil M
WUXI APPTEC CO., LTD.	-41,01 %	16,74 mil M
BEIGENE, LTD.	-14,85 %	16,05 mil M
NEUROCRINE BIOSCIENCES, INC.	+3,21 %	13,68 mil M
SAREPTA THERAPEUTICS, INC.	+33,54 %	12,17 mil M